The Body Covers:
The 6th International Congress on Drug Therapy in HIV Infection
Glasgow, United Kingdom

November 17-21, 2002

Conference Summaries

Coverage From Other Sources

This Congress addressed therapeutic research and treatment of HIV/AIDS, providing clinicians with current information and allowing researchers to keep abreast of emerging issues across the globe. For a PDF of the program, click here. Or visit their Web site.

Although there are important ongoing studies on therapeutic drug monitoring, it's still not used in the U.S. A group of experts has developed a list of key concepts regarding the use of therapeutic drug monitoring in routine HIV management, Dr. Jonathan Schapiro reports.

"Perhaps most important was the understanding that physicians must now concentrate not only on the power of specific drugs, but on drugs that will improve the quality of patients' lives." Read this terrific overview of HIV treatment from Dr. Simon D. Portsmouth.

Many patients may opt for an unstructured treatment interruption, and the dangers of this must be made clear to all patients. The only place for structured treatment interruptions at present is in the context of clinical trial. Dr. Simon D. Portsmouth reports from Glasgow.

Coverage Provided By:
Mark Nelson, M.A., M.B.B.S., M.R.C.P. Andrew Phillips, Ph.D.
Simon D. Portsmouth, M.B.Ch.B., M.R.C.P., Dip.G.U.M., D.F.F.P. Jonathan Schapiro, M.D.
Mark Wainberg, M.D.

Funding for this coverage is provided, in part, by an unrestricted grant from Gilead Sciences and GlaxoSmithKline.

All coverage is © 2002 Body Health Resources Corporation.

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.